Naproxen
- Product NDC
- 42291-628
- Requested package NDC
- 42291-628-60
- 11-digit product format
- 422910628
- Labeler code
- 42291
- Product ID
- 42291-628_d57e8058-bb78-3aa6-e053-2a95a90a1520
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA075927
- Marketing category
- ANDA
- Marketing start
- 2013-09-26
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 42291-628 | 42291-628-60 | D | Discontinued by firm | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075927-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | |
| A075927-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | |
| A075927-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075927-001 | AB |
| A075927-002 | AB |
| A075927-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2001-12-18 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2001-12-18 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A075927-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2001-12-18 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A075927-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075927-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075927-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075927-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075927-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075927-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075927-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075927-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075927-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075927-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075927-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A075927-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075927-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075927-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075927-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A075927-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-628-18 | EA - Each | 42291-628 | 31a19463-42d1-47fc-b22e-d899e364a81e | 1 | 2019-08-06 |
| 42291-628-20 | EA - Each | 42291-628 | 438937d9-1d21-4ab2-a7c1-e9344a83d86e | 1 | 2013-12-02 |
| 42291-628-60 | EA - Each | 42291-628 | 62eec5e8-c6f2-4bf2-bf1f-f9744ce9ecc1 | 1 | 2013-12-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN TABLET [AVKARE, INC.] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN TABLET [AVKARE, INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN TABLET [AVKARE, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN TABLET [AVKARE, INC.] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN TABLET [AVKARE, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | c5e52ddd-a909-487a-bb46-01ad35690665 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | A-S Medication Solutions | c5c8b6fd-f3f5-4fed-823c-9a80386b27b1 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | AvPAK | e6fbf8f1-b064-658d-17bb-e7d6320aa45f | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | ab6ec2c9-5df9-346c-e053-2a95a90ac81d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | QPharma, Inc. | 307aa67f-53b9-4c60-a328-091bbf6338d4 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 29d98cf3-a0f2-3f89-e054-00144ff88e88 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 6573681e-e9be-440f-a818-a533b744648e | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals LLC | c43a43e2-e867-448d-8f59-3efc7c077cbc | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 9d7bc470-fbba-40a6-a56c-f681a3cee9cf | 2025-03-24 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals of New York LLC | 2718e0b7-1ce6-457e-bee9-11b634dfd353 | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9ad850-57b5-a21d-e053-2a95a90ae68e | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9a94a8-3825-eabd-e053-2a95a90acd58 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | a4f31070-4ee1-4d64-8b1d-40b9011e124b | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 80233fa5-f8b4-42d5-a8c9-4a1d8fd4aba4 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 21930f73-d3c2-4462-a487-74ed871b74b2 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | A-S Medication Solutions | a5ea3a84-7acd-4f24-9f0f-9f871ce1b5f4 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | Proficient Rx LP | fc3ee94a-adb7-411e-a662-2f2c6ddbabaf | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
| Naproxen | NAPROXEN | NCS HealthCare of KY, Inc dba Vangard Labs | 62a12771-bde9-4bc3-9ce9-672c8e31f020 | 2017-10-12 | Boxed warning, Warnings, Adverse reactions | 075927 ANDA075927 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 42291-628-60 | 42291062860 | 60 TABLET in 1 BOTTLE (42291-628-60) | 60 tablet | 2013-09-26 | 0000-00-00 | No | No | Current |